Tofacitnib for the Treatment of Alopecia Areata and Variants
NCT02197455
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Alopecia Areata (AA)
Alopecia Totalis (AT)
Alopecia Universalis (AU)
Interventions
DRUG:
Tofacitinib Administration
Sponsor
Yale University